Stock ENBI ENTHEON BIOMEDICAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Entheon Biomedical Corp.

Equities

ENBI

CA29383X2023

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange
Other stock markets
 03:58:53 2024-12-06 pm EST 		5-day change 1st Jan Change
0.1750 CAD +9.38% Intraday chart for Entheon Biomedical Corp. +25.00% +75.00%
Dec. 02 Entheon Biomedical Corp. announced that it expects to receive CAD 0.3 million in funding CI
Oct. 24 Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2024 CI
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In

Latest news about Entheon Biomedical Corp.

Entheon Biomedical Corp. announced that it expects to receive CAD 0.3 million in funding Dec. 01 CI
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2024 Oct. 24 CI
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2024 Jul. 04 CI
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 29, 2024 Apr. 29 CI
Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding Apr. 17 CI
Entheon Biomedical Corp. announced that it expects to receive CAD 0.1475 million in funding Apr. 10 CI
Entheon Biomedical Corp. Reports Earnings Results for the Full Year Ended November 30, 2023 Mar. 25 CI
Entheon Biomedical Corp. Auditor Raises 'Going Concern' Doubt Mar. 25 CI
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023 23-10-25 CI
Entheon Biomedical Corp. Announces Termination of Andrew Hegle as Chief Science Officer 23-07-31 CI
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023 23-07-26 CI
Heading Health Inc. announced that it has received $4.5 million in funding from a group of investors 23-06-28 CI
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 28, 2023 23-04-28 CI
Entheon Biomedical Corp. Announces Termination of Consulting Agreement with Cybin 23-04-28 CI
Entheon Biomedical Corp. Auditor Raises 'Going Concern' Doubt 23-03-22 CI
Entheon Biomedical Corp. Announces Resignation of Ruth Chun as Director 23-03-02 CI
Entheon Biomedical Corp. Announces CFO Changes 23-01-05 CI
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022 22-10-31 CI
Entheon Biomedical Corp. Closes Patient Enrolment in its Clinical Research Study EBIQ-101 22-10-05 CI
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2022 22-07-26 CI
Entheon Biomedical Corp. cancelled the transaction announced on April 5, 2022 22-06-06 CI
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 28, 2022 22-04-29 CI
Entheon Biomedical Corp. announced that it expects to receive CAD 3 million in funding 22-04-04 CI
Entheon Biomedical Corp. Reports Earnings Results for the Full Year Ended November 30, 2021 22-03-30 CI
Entheon Biomedical Corp. Auditor Raises 'Going Concern' Doubt 22-03-29 CI

Chart Entheon Biomedical Corp.

Chart Entheon Biomedical Corp.
ENBI: Dynamic Chart

Company Profile

Logo Entheon Biomedical Corp.
Entheon Biomedical Corp. is a Canada-based biotechnology research and development company. The Company is interested in treating addiction and substance-use disorders.
Employees
1
Sector
Biotechnology & Medical Research
Calendar
2024-12-16 - Annual General Meeting
More about the company

Income Statement and Estimates

income-statement-evolution-chart ENTHEON-BIOMEDICAL-CORP More financial data
  1. Stock Market
  2. Equities
  3. ENBI Stock
  4. News Entheon Biomedical Corp.
  5. Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel, New Clinical Research Platform